The significance of GATA3 expression in breast cancer: a 10-year follow-up study

scientific article

The significance of GATA3 expression in breast cancer: a 10-year follow-up study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.HUMPATH.2008.09.010
P698PubMed publication ID19084267
P5875ResearchGate publication ID23665065

P2093author name stringJuan P Palazzo
Constantine Daskalakis
Vincenzo Ciocca
Robin M Ciocca
Alejandra Ruiz-Orrico
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)489-495
P577publication date2008-12-11
P1433published inHuman PathologyQ15756731
P1476titleThe significance of GATA3 expression in breast cancer: a 10-year follow-up study
P478volume40

Reverse relations

cites work (P2860)
Q43154830A study of immunohistochemical differential expression in pulmonary and mammary carcinomas
Q24653339Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer
Q36009818Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival
Q54499346Clinicopathological analysis of GATA3-positive breast cancers with special reference to response to neoadjuvant chemotherapy.
Q64095685Comprehensive analysis of the GATA transcription factor gene family in breast carcinoma using gene microarrays, online databases and integrated bioinformatics
Q28385752Cooperation of DLC1 and CDK6 affects breast cancer clinical outcome
Q35087772Decreased expression of the GATA3 gene is associated with poor prognosis in primary gastric adenocarcinoma
Q45918558Expression and relevance of TRPS-1: a new GATA transcription factor in breast cancer.
Q36036337GATA3 Expression Is a Poor Prognostic Factor in Soft Tissue Sarcomas
Q34817460GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation
Q54239056GATA3 expression in advanced breast cancer: prognostic value and organ-specific relapse.
Q37709554GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas
Q50727753GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival.
Q60908056Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer
Q34318251Higher levels of GATA3 predict better survival in women with breast cancer
Q42509280Immunohistochemical Analysis of the Expression of Breast Markers in Basal-like Breast Carcinomas Defined as Triple Negative Cancers Expressing Keratin 5.
Q44674039Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas
Q28534555Infrequent loss of luminal differentiation in ductal breast cancer metastasis
Q47137856Low expression of GATA3 promotes cell proliferation and metastasis in gastric cancer
Q38696793Markers of metastatic carcinoma of breast origin
Q86182716Polymorphic CT dinucleotide repeat in the GATA3 gene and risk of breast cancer in Iranian women
Q35000657Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth
Q36342134Prognostic and clinicopathological value of GATA binding protein 3 in breast cancer: A systematic review and meta-analysis
Q37200485Prognostic value of the trichorhinophalangeal syndrome-1 (TRPS-1), a GATA family transcription factor, in early-stage breast cancer
Q42730610Quantitative immunohistochemical analysis and prognostic significance of TRPS-1, a new GATA transcription factor family member, in breast cancer
Q60123325Regulation of the oncogenic phenotype by the nuclear body protein ZC3H8
Q35000662Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer
Q38798176The transcription factor GATA3 is required for homologous recombination repair by regulating CtIP expression
Q38526035Use of Immunohistochemical Stains in Epithelial Lesions of the Breast

Search more.